Keywords: Everolimus, Tuberous sclerosis complex, Tumors, Novartis

Everolimus shrinks brain tumors in children with tuberous sclerosis complex

Article | 14 November 2012

Everolimus, a drug originally developed to prevent the rejection of transplanted organs and is also marketed for the treatment of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in